Sean Carrick is the CEO of Nascent Biotech Inc. For over 30 years Mr. Carrick has been in a variety of life sciences companies, including time with Pfizer, Conmed and Maquet Medical, twenty-five of which have been in leadership roles. Mr. Carrick has also been part of several startup ventures including Praecis Pharma and Aveolus. Mr. Carrick was directly involved in a strategic partnership with Hisun Bioray of China. In his time at Nascent Mr. Carrick has led the development of Pritumumab from preclinical to Phase II ready and is currently exploring other therapeutic applications for PTB.

Lowell Holden has been the CFO and Chief Accounting Officer of the Company since May 2014.  Since 1983, Mr. Holden has owned and operated his own consulting firm, LS Enterprises, Inc., which provides business consulting, accounting and other services to businesses.  Mr. Holden has a broad range of business experience including managing, securing financing, structuring of transactions, and is experienced and knowledgeable in managing relationships with customers, financing institutions and stockholders. Mr. Holden also has a background in assisting companies in fulfilling their financial auditing and SEC reporting requirements. Mr. Lowell Holden has a Bachelor’s of Science degree from Iowa State University.